ALLMedicine™ Heparin-induced Thrombocytopenia Center
Research & Reviews 799 results
https://clinicaltrials.gov/ct2/show/NCT05382078
May 19th, 2022 - CRRT, the continuous renal replacement therapy, is widely applied in the field of intensive care medicine. This technology is known as an alternative therapy to save injured kidney with advantages of the accurate volume control, stable acid-alkali...
https://doi.org/10.1097/CRD.0000000000000457
Cardiology in Review; Herblum J, Frishman W
May 17th, 2022 - COVID-19 is a pro-thrombotic and cardiac-damaging disease. There are four vaccines against COVID-19 currently approved in North America, including the mRNA vaccines by Pfizer and Moderna, and the adenovirus vector vaccines by Johnson and Johnson a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969294
Journal of Cardiothoracic and Vascular Anesthesia; Yusuff H, Zochios V et. al.
May 17th, 2022 - Extracorporeal membrane oxygenation (ECMO) is an established part of the treatment algorithm for coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome. An intense inflammatory response may cause an imbalance in the coagul...
https://doi.org/10.1182/blood.2021014588
Blood Kanack A, Bayas A et. al.
May 14th, 2022 - COVID-19 vaccines have been associated with a rare life-threatening thrombotic and thrombocytopenic adverse reaction, vaccine-induced immune thrombotic thrombocytopenia (VITT) characterized by high levels of platelet-activating anti-platelet facto...
https://doi.org/10.1053/j.jvca.2022.03.043
Journal of Cardiothoracic and Vascular Anesthesia; Bolliger D, Santer D et. al.
May 11th, 2022 - Heparin-Induced Thrombocytopenia in Patients With Mechanical Circulatory Support.|2022|Bolliger D,Santer D,Tanaka KA,|
Guidelines 2 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258919
Blood Advances; Cuker A, Arepally GM et. al.
Nov 30th, 2018 - Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction mediated by platelet-activating antibodies that target complexes of platelet factor 4 and heparin. Patients are at markedly increased risk of thromboembolism. These evidence-based ...
https://doi.org/10.1378/chest.08-0677
Chest Warkentin TE, Greinacher A et. al.
Jul 24th, 2008 - This chapter about the recognition, treatment, and prevention of heparin-induced thrombocytopenia (HIT) is part of the Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th E...
Drugs 45 results see all →
Clinicaltrials.gov 20 results
https://clinicaltrials.gov/ct2/show/NCT05382078
May 19th, 2022 - CRRT, the continuous renal replacement therapy, is widely applied in the field of intensive care medicine. This technology is known as an alternative therapy to save injured kidney with advantages of the accurate volume control, stable acid-alkali...
https://clinicaltrials.gov/ct2/show/NCT05237843
Feb 14th, 2022 - Recurrent pregnancy loss (RPL) remains a significant challenge in obstetrical practice. It is not only emotionally devastating for expectant women but is also medically challenging. Approximately 1-3% of women have recurrent spontaneous abortion, ...
https://clinicaltrials.gov/ct2/show/NCT04066764
Sep 13th, 2021 - Deep vein thrombosis (DVT) of lower extremities is a venous reflux disorder caused by abnormal coagulation of deep vein blood. The main adverse consequences of DVT are pulmonary embolism (PE) and post-thrombotic syndrome, which can significantly a...
https://clinicaltrials.gov/ct2/show/NCT03659708
Jan 26th, 2021 - The management of venous thromboembolism (VTE) risk in pregnancy still remains a challenge. An individual assessment of the VTE risk is crucial for optimal thromboprophylaxis, but there is no validated tool to help clinicians stratify the risk in ...
https://clinicaltrials.gov/ct2/show/NCT01269112
Aug 14th, 2019 - monocentric prospective open-label randomized controlled trial at the ICU of the University Hospitals of Geneva (Switzerland). ICU patients eligible if they 18 yr old and had an AKI requiring CRRT Exclusion criteria Patients excluded if they had a...
News 61 results
https://www.mdedge.com/jcomjournal/article/252968/hospital-medicine/practical-and-cost-effective-approach-diagnosis-heparin
Alice Cusick, MD, Sarah Hanigan, PharmD et. al.
Mar 21st, 2022 - From the Veterans Affairs Ann Arbor Healthcare System Medicine Service (Dr. Cusick), University of Michigan College of Pharmacy, Clinical Pharmacy Service, Michigan Medicine (Dr.
https://www.mdedge.com/dermatology/article/247860/wounds/enoxaparin-induced-hemorrhagic-bullae-sites-trauma-and-endothelial
Michael L. Garner, MD, Laura G. Pruitt, MD et. al.
Oct 25th, 2021 - To the Editor: A 67-year-old man with diabetes mellitus was admitted to the hospital for exacerbation of congestive heart failure and atrial flutter with rapid ventricular response. He subsequently developed a non-ST segment elevation myocardial i.
https://www.medscape.com/viewarticle/955225
Jul 23rd, 2021 - NEW YORK (Reuters Health) - Organs from deceased donors who had received AstraZeneca's ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 may possibly prompt vaccine-induced thrombosis and thrombocytopenia (VITT) in recipients, according to a new study. A...
https://www.medscape.com/viewarticle/953901
Jun 28th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. What is believed to be the first case of thrombosis with thrombocytopenia after a messenger RNA COVID-19 vaccine has been reported. The case repor...
https://www.medpagetoday.com/infectiousdisease/covid19vaccine/93017
Jun 9th, 2021 - Intravenous immune globulin (IVIG) helped resolve the effects of vaccine-induced thrombotic thrombocytopenia (VITT) in three patients following receipt of the AstraZeneca COVID-19 vaccine, a case series in Canada found. Following administration of...
